Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spinal stimulation plus gait training: a new hope for leg movement after injury?

NCT ID NCT07375745

Disease control Sponsor: Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study tests whether adding a mild electrical stimulation to the spinal cord (tSCS) during walking therapy can improve leg movement in people with recent spinal cord injury (within 6 months). Forty participants will receive either real or sham stimulation during 20 training sessions. The goal is to see if the combination is safe, feasible, and leads to better motor recovery than walking therapy alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous spinal cord stimulation (tSCS)
What this could lead to
If it works, this could point toward a way to improve walking recovery early after spinal cord injury, when the nervous system is most adaptable.
What could go wrong
This is a small, early-stage feasibility study (40 people) with no blinding or placebo control. The stimulation may not provide added benefit over standard gait training alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * paraplegic or quadriplegic participants with a subacute spinal cord injury (sSCI), defined as the stage of spinal cord damage occuring between 1 week and 6 months post-injury * above 16 years old * have a lesion between C1 - L2 * be considered as AIS A to D * be able to stay at least 10 minutes standing with or without assistance * can provide informed consent (no cognitive deficits by MoCA) * be able to follow instructions in French or English Exclusion Criteria: * pacemaker * active cancer on stimulation site or metastatic cancer * unhealed wound, scar or pain which makes positioning of the electrodes impossible * participants with specific contraindications to TMS (epilepsy, non-union cranial fracture and increased intracranial pressure) will be able to participate in the study, but will not receive TMS * chronic and severe neuropathic pain * pharmacology or implants that may impede with rehabilitation or spinal stimulation * pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gait disorder, sensorimotor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Gait Disorders, Neurologic Mobility Limitation spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gait disorder, sensorimotor Gait disorders Locomotion Spinal cord injury Spinal cord injury subacute

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institut de réadaptation Gingras-Lindsay-de-Montréal (IRGLM)

    Montreal, Quebec, H3S 2J4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.